Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8567778rdf:typepubmed:Citationlld:pubmed
pubmed-article:8567778lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:8567778lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:8567778lifeskim:mentionsumls-concept:C0013072lld:lifeskim
pubmed-article:8567778lifeskim:mentionsumls-concept:C0037868lld:lifeskim
pubmed-article:8567778lifeskim:mentionsumls-concept:C0332161lld:lifeskim
pubmed-article:8567778lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:8567778lifeskim:mentionsumls-concept:C0151721lld:lifeskim
pubmed-article:8567778lifeskim:mentionsumls-concept:C0076195lld:lifeskim
pubmed-article:8567778lifeskim:mentionsumls-concept:C0332240lld:lifeskim
pubmed-article:8567778lifeskim:mentionsumls-concept:C1516240lld:lifeskim
pubmed-article:8567778pubmed:issue10lld:pubmed
pubmed-article:8567778pubmed:dateCreated1996-3-1lld:pubmed
pubmed-article:8567778pubmed:abstractTextSeventy-seven couples in whom conventional in-vitro fertilization (IVF) had remained unsuccessful because of low fertilization rate and abnormal sperm characteristics were given either testosterone undecanoate 120 mg/day, or placebo during 3 months, after which a new IVF treatment was applied under identical technical conditions. There were no significant changes in sperm characteristics among the treated and placebo couples and the fertilization rate showed a similar increase after treatment in both groups. No significant difference in pregnancies occurred, with 32% pregnancies in the placebo controls and 17% among couples treated with testosterone undecanoate. It is concluded that testosterone undecanoate intake does not improve sperm characteristics, or the in-vitro fertilizing potential, or pregnancy rate over those observed in the placebo controls in cases with primary idiopathic testicular failure.lld:pubmed
pubmed-article:8567778pubmed:languageenglld:pubmed
pubmed-article:8567778pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8567778pubmed:citationSubsetIMlld:pubmed
pubmed-article:8567778pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8567778pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8567778pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8567778pubmed:statusMEDLINElld:pubmed
pubmed-article:8567778pubmed:monthOctlld:pubmed
pubmed-article:8567778pubmed:issn0268-1161lld:pubmed
pubmed-article:8567778pubmed:authorpubmed-author:ComhaireFFlld:pubmed
pubmed-article:8567778pubmed:authorpubmed-author:MilingosSSlld:pubmed
pubmed-article:8567778pubmed:authorpubmed-author:DhontMMlld:pubmed
pubmed-article:8567778pubmed:authorpubmed-author:GerrisJJlld:pubmed
pubmed-article:8567778pubmed:authorpubmed-author:GordtsSSlld:pubmed
pubmed-article:8567778pubmed:authorpubmed-author:CampyDDlld:pubmed
pubmed-article:8567778pubmed:authorpubmed-author:SchoonjansFFlld:pubmed
pubmed-article:8567778pubmed:authorpubmed-author:AbdelmassihRRlld:pubmed
pubmed-article:8567778pubmed:issnTypePrintlld:pubmed
pubmed-article:8567778pubmed:volume10lld:pubmed
pubmed-article:8567778pubmed:ownerNLMlld:pubmed
pubmed-article:8567778pubmed:authorsCompleteYlld:pubmed
pubmed-article:8567778pubmed:pagination2600-2lld:pubmed
pubmed-article:8567778pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8567778pubmed:meshHeadingpubmed-meshheading:8567778-...lld:pubmed
pubmed-article:8567778pubmed:meshHeadingpubmed-meshheading:8567778-...lld:pubmed
pubmed-article:8567778pubmed:meshHeadingpubmed-meshheading:8567778-...lld:pubmed
pubmed-article:8567778pubmed:meshHeadingpubmed-meshheading:8567778-...lld:pubmed
pubmed-article:8567778pubmed:meshHeadingpubmed-meshheading:8567778-...lld:pubmed
pubmed-article:8567778pubmed:meshHeadingpubmed-meshheading:8567778-...lld:pubmed
pubmed-article:8567778pubmed:meshHeadingpubmed-meshheading:8567778-...lld:pubmed
pubmed-article:8567778pubmed:meshHeadingpubmed-meshheading:8567778-...lld:pubmed
pubmed-article:8567778pubmed:meshHeadingpubmed-meshheading:8567778-...lld:pubmed
pubmed-article:8567778pubmed:meshHeadingpubmed-meshheading:8567778-...lld:pubmed
pubmed-article:8567778pubmed:meshHeadingpubmed-meshheading:8567778-...lld:pubmed
pubmed-article:8567778pubmed:meshHeadingpubmed-meshheading:8567778-...lld:pubmed
pubmed-article:8567778pubmed:year1995lld:pubmed
pubmed-article:8567778pubmed:articleTitleDoes treatment with testosterone undecanoate improve the in-vitro fertilizing capacity of spermatozoa in patients with idiopathic testicular failure? (results of a double blind study).lld:pubmed
pubmed-article:8567778pubmed:affiliationUniversity Hospital, Department of Internal Medicine, Ghent, Belgium.lld:pubmed
pubmed-article:8567778pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8567778pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:8567778pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:8567778pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed